Oct 24, 2024 · AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives

AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people’s lives.

Apr 18, 2022 · AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives.

The Investor Relations website contains information about AbbVie's business for stockholders, potential investors, and financial analysts.

AbbVie is committed to helping patients get the medicines they need. That’s why we offer patient assistance programs that provide free AbbVie medicines to qualifying patients.

Oct 24, 2024 · All product names are trademarks owned by or licensed to AbbVie Inc. or its subsidiaries. You are encouraged to report negative side effects of prescription drugs to the …

Oct 24, 2024 · AbbVie offers country-specific telephone numbers below to raise concerns and report suspected or actual violations.

Feb 14, 2025 · The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.64 per share. The cash dividend is payable May 15, 2025, to stockholders …

AbbVie: Who we are US-ABBV-200135 Therapeutic areas of focus: Immunology We leverage deep scientific expertise to develop next-generation biologics and small molecules in …

Jan 31, 2025 · a Represents net earnings attributable to AbbVie Inc. Intangible asset impairment reflects a partial after-tax impairment charge of $3.5 billion related to the emraclidine intangible …